The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials

Blood(2022)

引用 1|浏览26
暂无评分
关键词
venetoclax,induction chemotherapy,gimema aml1718,low-risk,score-matched
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要